Penumbra
Private Company
Funding information not available
Overview
Penumbra is a Germany-based, global medical device company that has established itself as a leader in mechanical thrombectomy for neurovascular and peripheral vascular diseases. The company's core technology platform revolves around aspiration-based systems, exemplified by its flagship Lightning Flash product line for treating pulmonary embolism and venous thrombosis. In a significant recent development, Boston Scientific announced an agreement to acquire Penumbra in January 2026, indicating the strategic value of its technology portfolio. Penumbra operates commercially with a direct sales model and maintains a strong focus on clinical evidence and physician training.
Technology Platform
Aspiration-based mechanical thrombectomy systems for neurovascular and peripheral vascular applications, comprising reperfusion catheters, separators, aspiration tubing, and a proprietary pump.
Opportunities
Risk Factors
Competitive Landscape
Penumbra competes in the crowded and innovative thrombectomy device market against major players like Medtronic, Stryker, and Johnson & Johnson. Its differentiation is based on its dedicated aspiration platform, particularly the Lightning Flash system for PE, competing against other mechanical thrombectomy and pharmaco-mechanical devices.